Trial intelligence / Profile preview

Tranexamic acid for bleeding reduction in cardiac surgery patients

IRCT2013071210311N3Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in coronary arteriosclerosis, sponsored by Shiraz University of Medical Sciences. Started Dec 2014; status: completed.

02

Drugs

tranexamic acid
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on IRCT2013071210311N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013071210311N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call